2Yaturu S,Bridges JE,Reddy DR,et al.Decreased levels of plasma adiponectin in prediabetes,Type 2 Diabetes and coronary artery disease.Med Sci Monit,2006,12:CR17-20.
3Sianos G,Morel MA,Kappetein AP,et al.The SYNTAX Score:an angiographic tool grading the complexity of coronary artery disease.Eurolnterv,2005,1:219-227.
4Frystyk J,Berne C,Berglund L,et al.Serum adiponectin is a predictor of coronary heart disease:a population-based 100 year follow-up study in elderly men.The Journal of Clinical Endocrinology & Metabolism,2007,92:571-576.
5Cavusoglu E,Ruwende C,Chopra V,et al.Adiponectin is an independent predictor of all-cause mortality,cardiac mortality,and myocardial infarction in patients presenting with chest pain.European Heart Journal,2006,27:2300-2309.
6Matthias B.Schulze,Iris Shai,Eric B.Rimm,et al.Adiponectin and future coronary heart disease events among men with type 2 diabetes.Diabetes,2005,54:534-539.
1Georgios S,Marie-angele M,Arie PK,et al.The SYNTAX Score:an angiographic tool grading the complexity of coronary artery disease.Euro Intervention,2005,2:219-227.
2Sc Berry C,Tardif JC,Bourassa MG,et al.Coronary heart disesse in patients with diabetes.JACC,2007,49:631-642.
3Schramm TK,Gislason GH,Kober L,et al.Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk.A population study of 3.3 million people.Circulation,2008,117:1945-1954.
4Laskey WK,Seizer F,Vlachos HA,et al.Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention(from the National Heart,Lung,and Blood Institute Dynamic Registry.Am J of Cardiol,2002,90:1062-1067.
5Falcone C,Nespoli L,Geroldi D,et al.Silent myocardial ischemia in diabetic and noondiabetic patientswith coronary artery disease.Int J Cardiol,2003,90:219-227.
